Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Canine Arthritis Treatment Market
Canine Arthritis Treatment Market Trends
- Report ID: GMI8835
- Published Date: Apr 2024
- Report Format: PDF
Canine Arthritis Treatment Market Trends
- The global market for canine arthritis treatments is being driven by a growing awareness pertaining to their pet health and pet care. Globally, the number of disease cases in dogs and cats has increased recently. It involves decreased appetite, allergies, arthritis, dysplasia, and behavioral anxiety in animals. This factor is emphasizing the need for novel drugs and treatment to eliminate the possibility of canine arthritis in animals. However, high cost of treatment may hamper the market growth to certain extent.
Frequently Asked Questions (FAQ) :
Canine arthritis treatment industry size was worth USD 2.4 billion in 2023 and will exhibit a 4.7% CAGR between 2024 and 2032 due to the rising incidence of arthritis and related conditions in canines.
The osteoarthritis segment in the canine arthritis treatment industry will reach USD 1.4 billion by 2032, driven by the high prevalence of osteoarthritis among dogs coupled with aging population of dogs, rise in pet obesity and advancements in veterinary medicine.
North America canine arthritis treatment market recorded USD 1 billion in 2023 and will grow at 4.6% CAGR from 2024 to 2032, attributed to the growing prevalence of canine arthritis, and rise in per capita animal healthcare expenditure in the region.
Some of the key canine arthritis treatment companies are American Regent, Inc., Bayer AG, Boehringer Ingelheim Animal Health, CEVA Sant
Canine Arthritis Treatment Market Scope
×
Get a free sample of
Canine Arthritis Treatment Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below